$TBIOAgain took some profits This stock is a gold mine. Very low public float, underfollowed, nice movesLongby Ray0
TBIO: Breakout Confirmed, 36.58% Potential Profit!Description: TBIO is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position. Stats: 1. Ideal buy range: $21.5 - $23.2 2. Take profit: $30.02 3. Stop Loss: $20.3 4. Risk To Reward: 1 / 5 5. Accuracy Rating: 88%Longby tenpercentcreditspreads3
TBIO S&R levelsI believe that the dip we have recently seen in TBIO will provide for a good buying opportunity if it can hit the support levels that would minimize the risk of losses. Surely a bounce is awaiting, especially with all the complications that have recently arisen due to the covid vaccinations. Expect this to go well into the $20s. Timeframe: Short term 3-6 months. by kambach1
TBIO Retesting the BreakoutI don't have a position here, but watching to see how it acts. I'd like to see some buying at the 10-day and at prior highs. The question is whether the breakout was a fakeout or if this is just a retest. We'll know soon enough. by mroberts12042
My Prediction For TBIOAlthough Translate Bio. is one of the best companies in term of fundamentals, it also has a great technicals. As per our ovservation the price has already broke through a cup and handle pattern and currently it is settling on the neckline. Once the price pounces off the neckline I will be looking towards 34$ as the first target. Then 43$ as a final TP.Longby MahdiAlQallaf0
$TBIOEntry price : 22.39 Fundamentals : - Sector: Medical - Biotech - EPS % Chg (Last Qtr): 158% - EPS % Chg (Previous Qtr): -2% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 5149% - Sales % Chg (Previous Qtr): 1290% - 3-Year Sales Growth Rate: 992% - Annual Pre -Tax Margin: -1220%Longby paulopicaocapeloUpdated 0
$TBIO Translate Bio trade to ATH Potential long entry above $ 25.50 Targets price $28.00Longby RedHotStocks3
TBIO bullish macd cross over. Target 1: 17.50 (+10%). Target 2: TBIO bullish macd cross over. Target 1: 17.50 (+10%). Target 2: 20.26Longby Therealbouga112
Sanofi and Translate Bio Expand CollaborationSanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas Translate Bio to receive $425 million in upfront payment and common stock equity investment and overall is eligible to receive up to $1.9 billion of potential milestones/payments as well as tiered royalties on worldwide sales of developed vaccines Sanofi to receive exclusive worldwide rights to develop, manufacture and commercialize infectious disease vaccines using Translate Bio technology The expanded collaboration brings together Translate Bio’s leading mRNA technology and manufacturing with Sanofi’s world class vaccine development and distribution Translate Bio will receive a total upfront payment of $425 million, consisting of a $300 million cash payment and a private placement common stock investment of $125 million at $25.59 per share representing a 50 percent premium to the 20-day moving average share price prior to signing. Translate Bio will also be eligible for potential future milestones and other payments up to $1.9 billion, including $450 million of milestones under the 2018 agreement. Of these potential milestones and other payments, approximately $360 million are anticipated over the next several years, inclusive of COVID-19 vaccine development milestones. finance.yahoo.com The deal strengthens Sanofi's credentials in a market engaged in a frantic race to find a safe and effective vaccine against the coronavirus disease that has killed more than 472,000 worldwide. finance.yahoo.com Sanofi Pasteur will pay for all costs during the collaboration term and receive exclusive worldwide rights for infectious disease vaccines. finance.yahoo.com Sanofi expects to win approval for a Covid-19 vaccine in the first half of next year as it strengthens a pact with Translate Bio Inc. to develop other shots in a deal that could be valued at as much as $2.3 billion. finance.yahoo.com www.barrons.com www.thestreet.com finance.yahoo.comby AlenCiken6
$TBIO on breakout alert $28 potential upside target The Company will present and host one-on-one meetings at the following virtual investment banking conferences: Bank of America Healthcare Conference 2020, May 12-15, 2020 Jefferies Virtual Healthcare Conference, June 2-4, 2020by DEXWireNews1117